Skip to content
Third-party HPLC + mass spec on every lot
Verified — all release criteria met
releasedCurrent lot

Certificate of analysis

Tesamorelin

Lot CP-TESAMOS2-2607A · 5 mg

99.71 %

HPLC purity

Spec ≥ 98.0 %

90.7 %

Net peptide content

By amino acid analysis

< 0.17

Endotoxin (EU/mg)

Spec < 5.0 EU/mg

Provenance

Testing laboratory
Janoshik Analytical
Accreditation
ISO/IEC 17025:2017
Country of synthesis
United States
Manufactured
Jul 13, 2026
Release tested
Jul 22, 2026 (2 months ago)
Retest date
Jul 12, 2028
CAS number
218949-48-5
Molecular formula
C221H366N72O67S
Theoretical mass
5135.90 Da
Observed mass (LC-MS)
5135.84 Da (Δ 0.06 Da)

Assay results

Every line the release panel ran for this lot, with the method, the acceptance criterion and the measured value — not a pass mark alone.

Certificate of analysis — assay results
MethodParameterSpecificationResult
RP-HPLC (UV 214 nm)Purity (area %)≥ 98.0 %99.71 %Pass
LC-MS (ESI+)Identity — observed mass5135.90 ± 1.0 Da5135.84 DaPass
Amino acid analysisNet peptide content≥ 80.0 %90.7 %Pass
Karl FischerWater content≤ 8.0 %5.07 %Pass
Ion chromatographyResidual TFA≤ 1.0 %0.16 %Pass
LAL kinetic chromogenicBacterial endotoxin< 5.0 EU/mg< 0.17 EU/mgPass
USP <71> membrane filtrationSterilityNo growthNo growthPass
Visual / USP <790>AppearanceWhite to off-white cake, free of visible particulatesConformsPass

Handling for this lot

Appearance
White lyophilised cake
Storage
-20 °C lyophilised. Reconstituted material is comparatively fragile — use within 14 days at 2–8 °C.
Reconstitution
Swirl gently. As a 44-mer this peptide is more shear-sensitive than the short secretagogues.

Other lots of Tesamorelin

Compare batch to batch. Consistency across lots is a stronger signal than any single certificate.

Research use only. This certificate describes material supplied strictly for laboratory research. It is not a drug, food, cosmetic or medical device, has not been evaluated by the FDA, and is not intended for human or veterinary administration of any kind.